Placenta Diseases
23
3
4
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.7%
2 terminated out of 23 trials
85.7%
-0.8% vs benchmark
4%
1 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (23)
Characterization of Placental Diffusion
Investigating CD 71 in Preeclamptic Pregnancies
Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane
The Impact of Opioid and Cannabis Exposure on Fetal Growth
Effects of Tuberculosis Infection on Development and Function of the Placenta
Angiogenic Factors in the Placentas of Women With COVID-19
Plasma Concentration of Biological Markers in Placenta Accreta Spectrum
Effects of Smoking on Placenta and Lactation
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
PregSource: Crowdsourcing to Understand Pregnancy
The START Clinic: a Feasibility Study
The Effect of Anemia in Adolescent and Advanced Age Pregnancies
Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
MARS: Magnetic Resonance Study: A Novel Assessment of Placental Function
Near-infrared Spectroscopy: Differences in Placental Oxygenation in Relation to Ultrasound Maturation Grade in physiologIcal Term Pregnancies
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Placental Perfusion in the Entire Placenta and With Sonobiopsy by Ultrasound
Ultrasound Diagnosis of Placental and Umbilical Cord Anomalies in Singleton Pregnancies Resulting From In-vitro Fertilization
COVID-19 Infection and Fetal-neonatal Outcomes
Study on Retroplacental Hematomas in Finistère